Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Alzamend Neuro, Inc.

ALZN · Nasdaq · CIK 0001677077 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

1 Form 4 transaction lines observed in the same window
1 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2026-04-14 · AULT MILTON C III · $108.4K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
AULT MILTON C IIIDirector
▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

43.2 / 100

Latest recorded score

→ +0.0 ptsversus the previous recorded snapshot
  1. 43.2

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

5Purchases
4Sales
0Other Form 4 lines
7SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING1 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-21.2%
3M
+15.5%
6M
+56.2%
12M
-47.0%

Volatility & liquidity

Volatility
92.8%
Beta
—
Avg daily value
USD 117,903

Valuation

Market cap
USD 6.5M
P/E
—

Fundamentals

Profit margin
—
ROE
-1196.4%
Industry
Biotechnology

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, ROE · Fiscal year ended: 2026-04-30 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-09-10 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
111,547
Previous report
123,017
Avg daily volume
101,975
Days to cover
1.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock110,388USD 1.00USD 110,448SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock110,388USD 1.00USD 110,448SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock108,388USD 1.00USD 108,388SEC filing ↗
2025-03-26Horne William B.Purchase (P)Common Stock3,334USD 0.99USD 3,301SEC filing ↗
2025-03-21AULT MILTON C IIIPurchase (P)Common Stock2,905USD 1.02USD 2,963SEC filing ↗
2025-03-21Katzoff David JPurchase (P)Common Stock5,000USD 1.01USD 5,050SEC filing ↗
2025-03-20Horne William B.Purchase (P)Common Stock5,000USD 0.98USD 4,900SEC filing ↗
2025-03-18Horne William B.Purchase (P)Common Stock5,000USD 0.97USD 4,850SEC filing ↗
2025-03-18AULT MILTON C IIIPurchase (P)Common Stock5,000USD 0.96USD 4,800SEC filing ↗
2025-03-12AULT MILTON C IIIPurchase (P)Common Stock100USD 0.68USD 68SEC filing ↗
2024-08-06AULT MILTON C IIIPurchase (P)Common Stock75USD 2.75USD 206SEC filing ↗
2024-07-31AULT MILTON C IIIPurchase (P)Common Stock25USD 3.74USD 94SEC filing ↗
2024-04-19AULT MILTON C IIIPurchase (P)Common Stock1,000USD 0.69USD 690SEC filing ↗
2024-04-01AULT MILTON C IIIPurchase (P)Common Stock334USD 0.91USD 304SEC filing ↗
2024-01-05AULT MILTON C IIIPurchase (P)Common Stock2,000USD 1.06USD 2,120SEC filing ↗

Form 4 evidence

9 transaction lines in the latest 365-day window; 205 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-26AULT MILTON C IIISale (S)Common Stock2,000USD 1.56USD 3,120SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock110,388USD 1.00USD 110,448SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock110,388USD 1.00USD 110,448SEC filing ↗
Show recent Form 4 evidence (7 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-26AULT MILTON C IIISale (S)Common Stock2,000USD 1.56USD 3,120SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock110,388USD 1.00USD 110,448SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock110,388USD 1.00USD 110,448SEC filing ↗
2026-04-14AULT MILTON C IIIPurchase (P)Common Stock108,388USD 1.00USD 108,388SEC filing ↗
2025-12-23AULT MILTON C IIISale (S)Common Stock1,851USD 2.07USD 3,832SEC filing ↗
2025-12-19Horne William B.Sale (S)Common Stock3,333USD 2.12USD 7,066SEC filing ↗
2025-10-23McGrath Lynne FaheySale (S)Common Stock30USD 2.29USD 69SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerALZN
CIK0001677077
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history205 transaction lines from 2021-06-15 to 2026-08-26
132 P purchase lines · 37 S sale lines · 36 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.